BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6762091)

  • 1. Plasma exchange in Goodpasture's syndrome.
    Simpson IJ; Doak PB; Williams LC; Blacklock HA; Hill RS; Teague CA; Herdson PB; Wilson CB
    Am J Nephrol; 1982; 2(6):301-11. PubMed ID: 6762091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of plasma exchange and immunosuppression to improve renal function in Goodpasture's syndrome.
    McLeish KR; Maxwell DR; Luft FC
    Clin Nephrol; 1978 Aug; 10(2):71-3. PubMed ID: 699402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of circulating anti-glomerular basement membrane antibody three years after immunosuppressive treatment and plasma exchange.
    Hind CR; Bowman C; Winearls CG; Lockwood CM
    Clin Nephrol; 1984 Apr; 21(4):244-6. PubMed ID: 6733989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation, immunosuppression and plasmapheresis in Goodpasture's syndrome.
    Cove-Smith JR; McLeod AA; Blamey RW; Knapp MS; Reeves WG; Wilson CB
    Clin Nephrol; 1978 Mar; 9(3):126-8. PubMed ID: 346273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoadsorption in Goodpasture's syndrome.
    Laczika K; Knapp S; Derfler K; Soleiman A; Hörl WH; Druml W
    Am J Kidney Dis; 2000 Aug; 36(2):392-5. PubMed ID: 10922318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goodpasture's disease: a report of ten cases and a review of the literature.
    Dammacco F; Battaglia S; Gesualdo L; Racanelli V
    Autoimmun Rev; 2013 Sep; 12(11):1101-8. PubMed ID: 23806563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge issues in Goodpasture's disease.
    Chan AL; Louie S; Leslie KO; Juarez MM; Albertson TE
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):151-62. PubMed ID: 21207195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and morphological aspects of the management of crescentic anti-glomerular basement membrane antibody (anti-GBM) nephritis/Goodpasture's syndrome.
    Walker RG; Scheinkestel C; Becker GJ; Owen JE; Dowling JP; Kincaid-Smith P
    Q J Med; 1985 Jan; 54(213):75-89. PubMed ID: 3975346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome.
    Lockwood CM; Rees AJ; Pearson TA; Evans DJ; Peters DK; Wilson CB
    Lancet; 1976 Apr; 1(7962):711-5. PubMed ID: 56532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [GOODPASTURE'S SYNDROME--CASE REPORTS].
    Kotur G; Kotur G; Horvatić I; Galešić D; Jubanović L; Galešić K
    Lijec Vjesn; 2015; 137(5-6):171-6. PubMed ID: 26380476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Goodpasture's syndrome with asymptomatic renal involvement. Disappearance of antiglomerular basement membrane antibodies deposits after treatment.
    Lamriben L; Kourilsky O; Mougenot B; Ronco P; Sraer JD
    Nephrol Dial Transplant; 1993; 8(11):1267-9. PubMed ID: 8302468
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of Goodpasture's syndrome with immunosuppression and plasmapheresis.
    Finch RA; Rutsky EA; McGowan E; Wilson CB
    South Med J; 1979 Oct; 72(10):1288-90. PubMed ID: 482987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiglomerular basement membrane antibody-mediated glomerulonephritis and Goodpasture's syndrome.
    Briggs WA; Johnson JP; Teichman S; Yeager HC; Wilson CB
    Medicine (Baltimore); 1979 Sep; 58(5):348-61. PubMed ID: 384140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goodpasture's syndrome--a case report.
    Yang CW; Huang CC; Hsueh S
    Changgeng Yi Xue Za Zhi; 1990 Jun; 13(2):143-51. PubMed ID: 2224607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.
    Levy JB; Turner AN; Rees AJ; Pusey CD
    Ann Intern Med; 2001 Jun; 134(11):1033-42. PubMed ID: 11388816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques.
    Salama AD; Dougan T; Levy JB; Cook HT; Morgan SH; Naudeer S; Maidment G; George AJ; Evans D; Lightstone L; Pusey CD
    Am J Kidney Dis; 2002 Jun; 39(6):1162-7. PubMed ID: 12046026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Goodpasture's disease by plasma exchange and immunosuppression.
    Swainson CP; Robson JS; Urbaniak SJ; Keller AJ; Kay AB
    Clin Exp Immunol; 1978 May; 32(2):233-42. PubMed ID: 668199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmapheresis and immunosuppressive agents in antibasement membrane antibody-induced Goodpasture's syndrome.
    Johnson JP; Whitman W; Briggs WA; Wilson CB
    Am J Med; 1978 Feb; 64(2):354-9. PubMed ID: 629280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Goodpasture's disease or syndrome? Apropos of a case].
    Berti F; Carnabuci A; Onetti A; Polchi S; Sorrentino R
    Recenti Prog Med; 1997 Jan; 88(1):26-31. PubMed ID: 9102711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
    Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
    Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.